{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:36:29Z","timestamp":1793723789321,"version":"4.6.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260468"],"award-info":[{"award-number":["82260468"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Guangxi","award":["2023GXNSFAA026341, 2023GXNSFAA026143 and 2025GXNSFAA069965"],"award-info":[{"award-number":["2023GXNSFAA026341, 2023GXNSFAA026143 and 2025GXNSFAA069965"]}]},{"name":"National Natural Science Foundation Cultivation Fund of the People's Hospital of Guangxi Zhuang Autonomous Region","award":["NSFC-HCF2025012"],"award-info":[{"award-number":["NSFC-HCF2025012"]}]},{"name":"Guangxi Medical and Health Appropriate Technology Development and Promotion Project","award":["S2024006"],"award-info":[{"award-number":["S2024006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00798-0","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:47:00Z","timestamp":1776430020000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Gene-guided repurposing identifies dihydroergotamine as a candidate inhibitor of the BCL2\u2013SIVA1 axis in advanced gastric cancer in vitro"],"prefix":"10.1186","volume":"21","author":[{"given":"Yu-Liang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Xing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Yi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Dong","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Gang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Rui","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Bin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao-Ren","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Man","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Dong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan-Biao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"issue":"3","key":"798_CR1","doi-asserted-by":"publisher","first-page":"534542","DOI":"10.1016\/j.cgh.2019.07.045","volume":"18","author":"AP Thrift","year":"2020","unstructured":"Thrift AP, El-Serag HB. Burden of Gastric Cancer[J]. Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J Am Gastroenterol Assoc. 2020;18(3):534542. https:\/\/doi.org\/10.1016\/j.cgh.2019.07.045.","journal-title":"J Am Gastroenterol Assoc"},{"key":"798_CR2","doi-asserted-by":"publisher","unstructured":"Morgan E, Arnold M, Camargo MC, et al. The current and future incidence and mortality of gastric cancer in 185 countries, 2020\u201340: a population-based modelling study[J]. eClinicalMedicine, Elsevier. 2022;47. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101404.","DOI":"10.1016\/j.eclinm.2022.101404"},{"key":"798_CR3","doi-asserted-by":"publisher","first-page":"149365","DOI":"10.1016\/j.gene.2025.149365","volume":"950","author":"NS Parducci","year":"2025","unstructured":"Parducci NS, Garnique ADMB, De Almeida BO, et al. Exploring the dual role of SIVA1 in cancer biology[J]. Gene. 2025;950:149365. https:\/\/doi.org\/10.1016\/j.gene.2025.149365.","journal-title":"Gene"},{"key":"798_CR4","doi-asserted-by":"publisher","unstructured":"Li N, Jiang P, Du W, et al. Siva1 suppresses epithelial-mesenchymal transition and metastasis of tumor cells by inhibiting stathmin and stabilizing microtubules[J]. Proc Natl Acad Sci USA. 2011;108(31): 1285112856. https:\/\/doi.org\/10.1073\/pnas.1017372108.","DOI":"10.1073\/pnas.1017372108"},{"issue":"6","key":"798_CR5","doi-asserted-by":"publisher","first-page":"622635","DOI":"10.1158\/2159-8290.CD-14-0921","volume":"5","author":"JL Van Nostrand","year":"2015","unstructured":"Van Nostrand JL, Brisac A, Mello SS, et al. The p53 Target Gene SIVA Enables Non-Small Cell Lung Cancer Development[J]. Cancer Discov. 2015;5(6):622635. https:\/\/doi.org\/10.1158\/2159-8290.CD-14-0921.","journal-title":"Cancer Discov"},{"issue":"2","key":"798_CR6","doi-asserted-by":"publisher","first-page":"15581566","DOI":"10.3892\/mmr.2020.11211","volume":"22","author":"F-B Kong","year":"2020","unstructured":"Kong F-B, Deng Q-M, Deng H-Q, et al. Siva\u20131 regulates multidrug resistance of gastric cancer by targeting MDR1 and MRP1 via the NF\u2013\u03baB pathway[J]. Mol Med Rep Spandidos Publications. 2020;22(2):15581566. https:\/\/doi.org\/10.3892\/mmr.2020.11211.","journal-title":"Mol Med Rep Spandidos Publications"},{"issue":"12","key":"798_CR7","doi-asserted-by":"publisher","first-page":"53015309","DOI":"10.1158\/0008-5472.CAN-04-3270","volume":"65","author":"F Chu","year":"2005","unstructured":"Chu F, Barkinge J, Hawkins S, et al. Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2[J]. Cancer Res. 2005;65(12):53015309. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3270.","journal-title":"Cancer Res"},{"issue":"13","key":"798_CR8","doi-asserted-by":"publisher","first-page":"43014312","DOI":"10.7150\/jca.92963","volume":"15","author":"F-B Kong","year":"2024","unstructured":"Kong F-B, Shi Z-Y, Huang Y-L, et al. SIVA-1 interaction with PCBP1 serves as a predictive biomarker for cisplatin sensitivity in gastric cancer and its inhibitory effect on tumor growth in vivo[J]. J Cancer. 2024;15(13):43014312. https:\/\/doi.org\/10.7150\/jca.92963.","journal-title":"J Cancer"},{"issue":"22","key":"798_CR9","doi-asserted-by":"publisher","first-page":"12441","DOI":"10.3390\/ijms252212441","volume":"25","author":"AH Al Khzem","year":"2024","unstructured":"Al Khzem AH, Gomaa MS, Alturki MS, et al. Drug Repurposing for Cancer Treatment: A Comprehensive Review[J]. Int J Mol Sci Multidisciplinary Digit Publishing Inst. 2024;25(22):12441. https:\/\/doi.org\/10.3390\/ijms252212441.","journal-title":"Int J Mol Sci Multidisciplinary Digit Publishing Inst"},{"issue":"11","key":"798_CR10","doi-asserted-by":"publisher","first-page":"55955623","DOI":"10.1021\/acs.jcim.0c00613","volume":"60","author":"T-S Lee","year":"2020","unstructured":"Lee T-S, Allen BK, Giese TJ, et al. Alchemical Binding Free Energy Calculations in AMBER20: Advances and Best Practices for Drug Discovery[J]. J Chem Inf Model. 2020;60(11):55955623. https:\/\/doi.org\/10.1021\/acs.jcim.0c00613.","journal-title":"J Chem Inf Model"},{"issue":"9","key":"798_CR11","doi-asserted-by":"publisher","first-page":"11571174","DOI":"10.1002\/jcc.20035","volume":"25","author":"J Wang","year":"2004","unstructured":"Wang J, Wolf RM, Caldwell JW, et al. Development and testing of a general amber force field[J]. J Comput Chem. 2004;25(9):11571174. https:\/\/doi.org\/10.1002\/jcc.20035.","journal-title":"J Comput Chem"},{"key":"798_CR12","doi-asserted-by":"publisher","first-page":"155179","DOI":"10.1146\/annurev.biophys.28.1.155","volume":"28","author":"C Sagui","year":"1999","unstructured":"Sagui C, Darden TA. Molecular dynamics simulations of biomolecules: long-range electrostatic effects[J]. Annu Rev Biophys Biomol Struct. 1999;28:155179. https:\/\/doi.org\/10.1146\/annurev.biophys.28.1.155.","journal-title":"Annu Rev Biophys Biomol Struct"},{"issue":"5","key":"798_CR13","doi-asserted-by":"publisher","first-page":"501508","DOI":"10.1002\/1096-987X(20010415)22","volume":"22","author":"V Kr\u00e4utler","year":"2001","unstructured":"Kr\u00e4utler V, Van Gunsteren WF, H\u00fcnenberger PH. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations[J]. J Comput Chem. 2001;22(5):501508. https:\/\/doi.org\/10.1002\/1096-987X(20010415)22. :5%3C501::AID-JCC1021%3E3.0.CO;2-V.","journal-title":"J Comput Chem"},{"issue":"10","key":"798_CR14","doi-asserted-by":"publisher","first-page":"104101","DOI":"10.1063\/1.2464095","volume":"126","author":"L Larini","year":"2007","unstructured":"Larini L, Mannella R, Leporini D. Langevin stabilization of molecular-dynamics simulations of polymers by means of quasisymplectic algorithms[J]. J Chem Phys. 2007;126(10):104101. https:\/\/doi.org\/10.1063\/1.2464095.","journal-title":"J Chem Phys"},{"issue":"4","key":"798_CR15","doi-asserted-by":"publisher","first-page":"797810","DOI":"10.1002\/jcc.21372","volume":"31","author":"G Rastelli","year":"2010","unstructured":"Rastelli G, Del Rio A, Degliesposti G, et al. Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA[J]. J Comput Chem. 2010;31(4):797810. https:\/\/doi.org\/10.1002\/jcc.21372.","journal-title":"J Comput Chem"},{"issue":"4","key":"798_CR16","doi-asserted-by":"publisher","first-page":"20202034","DOI":"10.1021\/ct3010485","volume":"9","author":"H Nguyen","year":"2013","unstructured":"Nguyen H, Roe DR, Simmerling C. Improved Generalized Born Solvent Model Parameters for Protein Simulations[J]. J Chem Theory Comput. 2013;9(4):20202034. https:\/\/doi.org\/10.1021\/ct3010485.","journal-title":"J Chem Theory Comput"},{"issue":"3","key":"798_CR17","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak A, Vazquez F, Montgomery PG, et al. Defining a Cancer Dependency Map[J]. Cell. 2017;170(3):564\u2013e57616. https:\/\/doi.org\/10.1016\/j.cell.2017.06.010.","journal-title":"Cell"},{"issue":"7757","key":"798_CR18","doi-asserted-by":"publisher","first-page":"503508","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi M, Huang FW, Jan\u00e9-Valbuena J, et al. Next-generation characterization of the Cancer Cell Line Encyclopedia[J]. Nat Nat Publishing Group. 2019;569(7757):503508. https:\/\/doi.org\/10.1038\/s41586-019-1186-3.","journal-title":"Nat Nat Publishing Group"},{"issue":"4","key":"798_CR19","doi-asserted-by":"publisher","first-page":"455463","DOI":"10.1007\/s12013-020-00929-y","volume":"78","author":"X-T Wang","year":"2020","unstructured":"Wang X-T, Li L, Kong F-B, et al. Lentivirus-Mediated Overexpression of SIVA-1 Reverses Cisplatin Resistance in Gastric Cancer in vitro[J]. Cell Biochem Biophys. 2020;78(4):455463. https:\/\/doi.org\/10.1007\/s12013-020-00929-y.","journal-title":"Cell Biochem Biophys"},{"key":"798_CR20","doi-asserted-by":"publisher","unstructured":"Evans IM, Paliashvili K. Co-immunoprecipitation Assays[J]. Methods Mol Biol. Clifton, N.J. 2022;2475: 125132. https:\/\/doi.org\/10.1007\/978-1-0716-2217-9_8.","DOI":"10.1007\/978-1-0716-2217-9_8"},{"issue":"1","key":"798_CR21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12885-023-10707-7","volume":"23","author":"H Wang","year":"2023","unstructured":"Wang H, Cui H, Yang X, et al. TUBA1C: a new potential target of LncRNA EGFR-AS1 promotes gastric cancer progression[J]. BMC Cancer. 2023;23(1):258. https:\/\/doi.org\/10.1186\/s12885-023-10707-7.","journal-title":"BMC Cancer"},{"key":"798_CR22","doi-asserted-by":"publisher","unstructured":"Ding D, Wang X, Xuan R, et al. Ephrin\u2013B2 promotes gastric cancer growth by inhibiting apoptosis and regulating the cell cycle via the Wnt\/\u03b2\u2013catenin signaling pathway[J]. Int J Oncol. Spandidos Publications. 2026;68(1): 115. https:\/\/doi.org\/10.3892\/ijo.2025.5821.","DOI":"10.3892\/ijo.2025.5821"},{"issue":"1","key":"798_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12967-023-04625-2","volume":"22","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wang X, Liu W, et al. CircGLIS3 promotes gastric cancer progression by regulating the miR-1343-3p\/PGK1 pathway and inhibiting vimentin phosphorylation[J]. J Transl Med. 2024;22(1):251. https:\/\/doi.org\/10.1186\/s12967-023-04625-2.","journal-title":"J Transl Med"},{"issue":"6","key":"798_CR24","doi-asserted-by":"publisher","first-page":"634651","DOI":"10.1093\/clinchem\/hvaf043","volume":"71","author":"SA Bustin","year":"2025","unstructured":"Bustin SA, Ruijter JM, Van den Hoff MJB, et al. MIQE 2.0: Revision of the Minimum Information for Publication of Quantitative Real-Time PCR Experiments Guidelines[J]. Clin Chem. 2025;71(6):634651. https:\/\/doi.org\/10.1093\/clinchem\/hvaf043.","journal-title":"Clin Chem"},{"issue":"12","key":"798_CR25","doi-asserted-by":"publisher","first-page":"100297","DOI":"10.1016\/j.mocell.2025.100297","volume":"48","author":"SG Ha","year":"2025","unstructured":"Ha SG, Park J-H, Kim M-Y, et al. Brief guide to western blot assays[J]. Mol Cells. 2025;48(12):100297. https:\/\/doi.org\/10.1016\/j.mocell.2025.100297.","journal-title":"Mol Cells"},{"issue":"suppl 5","key":"798_CR26","doi-asserted-by":"publisher","first-page":"v38v49","DOI":"10.1093\/annonc\/mdw350","volume":"27","author":"EC Smyth","year":"2016","unstructured":"Smyth EC, Verheij M, Allum W, et al. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol Off J Eur Soc Med Oncol. 2016;27(suppl 5):v38v49. https:\/\/doi.org\/10.1093\/annonc\/mdw350.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"8","key":"798_CR27","doi-asserted-by":"publisher","first-page":"24032414","DOI":"10.3748\/wjg.v22.i8.2403","volume":"22","author":"A Digklia","year":"2016","unstructured":"Digklia A, Wagner AD. Advanced gastric cancer: Current treatment landscape and future perspectives[J]. World J Gastroenterol. 2016;22(8):24032414. https:\/\/doi.org\/10.3748\/wjg.v22.i8.2403.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"798_CR28","doi-asserted-by":"publisher","first-page":"117122","DOI":"10.1007\/s13238-012-2018-5","volume":"3","author":"Y Mei","year":"2012","unstructured":"Mei Y, Wu M. Multifaceted functions of Siva-1: more than an Indian God of Destruction[J]. Protein Cell. 2012;3(2):117122. https:\/\/doi.org\/10.1007\/s13238-012-2018-5.","journal-title":"Protein Cell"},{"issue":"6","key":"798_CR29","doi-asserted-by":"publisher","first-page":"277288","DOI":"10.32604\/or.2022.027301","volume":"30","author":"F Kong","year":"2022","unstructured":"Kong F, Wu K, Pang L, et al. Inhibition of apoptosis-regulatory protein Siva-1 reverses multidrug resistance in gastric cancer by targeting PCBP1[J]. Oncol Res. 2022;30(6):277288. https:\/\/doi.org\/10.32604\/or.2022.027301.","journal-title":"Oncol Res"},{"key":"798_CR30","doi-asserted-by":"publisher","first-page":"63616367","DOI":"10.2147\/OTT.S173001","volume":"11","author":"J Vachtenheim","year":"2018","unstructured":"Vachtenheim J, Lischke R, Vachtenheim J. Siva-1 emerges as a tissue-specific oncogene beyond its classic role of a proapoptotic gene[J]. OncoTargets Ther. 2018;11:63616367. https:\/\/doi.org\/10.2147\/OTT.S173001.","journal-title":"OncoTargets Ther"},{"issue":"1","key":"798_CR31","doi-asserted-by":"publisher","first-page":"8395","DOI":"10.1023\/B:APPT.0000012125.01799.4c","volume":"9","author":"F Chu","year":"2004","unstructured":"Chu F, Borthakur A, Sun X, et al. The Siva-1 putative amphipathic helical region (SAH) is sufficient to bind to BCL-XL and sensitize cells to UV radiation induced apoptosis[J]. Apoptosis Int J Program Cell Death. 2004;9(1):8395. https:\/\/doi.org\/10.1023\/B:APPT.0000012125.01799.4c.","journal-title":"Apoptosis Int J Program Cell Death"},{"issue":"3","key":"798_CR32","doi-asserted-by":"publisher","first-page":"25332555","DOI":"10.1007\/s12013-024-01366-x","volume":"82","author":"S Ghosh","year":"2024","unstructured":"Ghosh S, Goswami D, Dutta R, et al. A Comprehensive Pan-Cancer Analysis of Cytochrome C Oxidase Assembly Factor 1 (COA1) Reveals Instrumental Role of Mitochondrial Protein Assembly in Cancer that Modulates Disease Progression and Prognostic Outcome[J]. Cell Biochem Biophys. 2024;82(3):25332555. https:\/\/doi.org\/10.1007\/s12013-024-01366-x.","journal-title":"Cell Biochem Biophys"},{"issue":"4","key":"798_CR33","doi-asserted-by":"publisher","first-page":"54015431","DOI":"10.1007\/s12013-025-01857-5","volume":"83","author":"D Goswami","year":"2025","unstructured":"Goswami D, Ghosh S, Dutta R, et al. Multi-omics Analysis Implicates Mitochondrial Complex Assembly Protein COX18 in Mitochondrial Signaling and Tumorigenesis across Cancers[J]. Cell Biochem Biophys. 2025;83(4):54015431. https:\/\/doi.org\/10.1007\/s12013-025-01857-5.","journal-title":"Cell Biochem Biophys"},{"key":"798_CR34","doi-asserted-by":"publisher","first-page":"513543","DOI":"10.1146\/annurev.iy.13.040195.002501","volume":"13","author":"S Cory","year":"1995","unstructured":"Cory S. Regulation of lymphocyte survival by the bcl-2 gene family[J]. Annu Rev Immunol. 1995;13:513543. https:\/\/doi.org\/10.1146\/annurev.iy.13.040195.002501.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"798_CR35","doi-asserted-by":"publisher","first-page":"7492","DOI":"10.1111\/imr.12939","volume":"299","author":"D Michaud","year":"2021","unstructured":"Michaud D, Steward CR, Mirlekar B, et al. Regulatory B cells in cancer[J]. Immunol Rev. 2021;299(1):7492. https:\/\/doi.org\/10.1111\/imr.12939.","journal-title":"Immunol Rev"},{"key":"798_CR36","doi-asserted-by":"publisher","unstructured":"Kasahara Y, Shirota H, Umegaki S, et al. Contribution of Fc\u03b3 receptor IIB to creating a suppressive tumor microenvironment in a mouse model[J]. Cancer Immunol. Immunother. CII. 2019;68(11): 1769~1778. https:\/\/doi.org\/10.1007\/s00262-019-02413-w.","DOI":"10.1007\/s00262-019-02413-w"},{"issue":"8","key":"798_CR37","doi-asserted-by":"publisher","first-page":"662674","DOI":"10.1038\/cmi.2017.35","volume":"14","author":"A Sarvaria","year":"2017","unstructured":"Sarvaria A, Madrigal JA, Saudemont A. B cell regulation in cancer and anti-tumor immunity[J]. Cell Mol Immunol. 2017;14(8):662674. https:\/\/doi.org\/10.1038\/cmi.2017.35.","journal-title":"Cell Mol Immunol"},{"key":"798_CR38","doi-asserted-by":"publisher","first-page":"150268","DOI":"10.1016\/j.bbrc.2024.150268","volume":"726","author":"S Ghosh","year":"2024","unstructured":"Ghosh S, Dutta R, Ghatak D, et al. Immunometabolic characteristics of Dendritic Cells and its significant modulation by mitochondria-associated signaling in the tumor microenvironment influence cancer progression[J]. Biochem Biophys Res Commun. 2024;726:150268. https:\/\/doi.org\/10.1016\/j.bbrc.2024.150268.","journal-title":"Biochem Biophys Res Commun"},{"key":"798_CR39","doi-asserted-by":"publisher","first-page":"115369","DOI":"10.1016\/j.bcp.2022.115369","volume":"208","author":"S Dubey","year":"2023","unstructured":"Dubey S, Ghosh S, Goswami D, et al. Immunometabolic attributes and mitochondria-associated signaling of Tumor-Associated Macrophages in tumor microenvironment modulate cancer progression[J]. Biochem Pharmacol. 2023;208:115369. https:\/\/doi.org\/10.1016\/j.bcp.2022.115369.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"798_CR40","doi-asserted-by":"publisher","first-page":"189471","DOI":"10.1016\/j.bbcan.2025.189471","volume":"1880","author":"S Ghosh","year":"2025","unstructured":"Ghosh S, Dutta R, Goswami D, et al. Mitochondrial dynamics and metabolic attributes regulate function of natural killer cell and infiltration in tumor microenvironment modulating disease progression[J]. Biochim Biophys Acta Rev Cancer. 2025;1880(6):189471. https:\/\/doi.org\/10.1016\/j.bbcan.2025.189471.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"798_CR41","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-024-01808-1","volume":"9","author":"Y Xia","year":"2024","unstructured":"Xia Y, Sun M, Huang H, et al. Drug repurposing for cancer therapy[J]. Signal Transduct Target Ther Nat Publishing Group. 2024;9(1):92. https:\/\/doi.org\/10.1038\/s41392-024-01808-1.","journal-title":"Signal Transduct Target Ther Nat Publishing Group"},{"issue":"5","key":"798_CR42","doi-asserted-by":"publisher","first-page":"291308","DOI":"10.1177\/2040620711413165","volume":"2","author":"W Rehman","year":"2011","unstructured":"Rehman W, Arfons LM, Lazarus HM. The Rise, Fall and Subsequent Triumph of Thalidomide: Lessons Learned in Drug Development[J]. Ther Adv Hematol. 2011;2(5):291308. https:\/\/doi.org\/10.1177\/2040620711413165.","journal-title":"Ther Adv Hematol"},{"key":"798_CR43","doi-asserted-by":"publisher","first-page":"741316","DOI":"10.3389\/fmolb.2021.741316","volume":"8","author":"V Kannappan","year":"2021","unstructured":"Kannappan V, Ali M, Small B, et al. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents[J]. Front Mol Biosci. 2021;8:741316. https:\/\/doi.org\/10.3389\/fmolb.2021.741316.","journal-title":"Front Mol Biosci"},{"key":"798_CR44","doi-asserted-by":"publisher","first-page":"110110","DOI":"10.1016\/j.abb.2024.110110","volume":"759","author":"S Ghosh","year":"2024","unstructured":"Ghosh S, Ghatak D, Dutta R, et al. PINK1 insufficiency can be exploited as a specific target for drug combinations inducing mitochondrial pathology-mediated cell death in gastric adenocarcinoma[J]. Arch Biochem Biophys. 2024;759:110110. https:\/\/doi.org\/10.1016\/j.abb.2024.110110.","journal-title":"Arch Biochem Biophys"},{"issue":"6","key":"798_CR45","doi-asserted-by":"publisher","first-page":"304312","DOI":"10.1159\/000445044","volume":"61","author":"S-H Chang","year":"2016","unstructured":"Chang S-H, Lee AY, Yu K-N, et al. Dihydroergotamine Tartrate Induces Lung Cancer Cell Death through Apoptosis and Mitophagy[J]. Chemotherapy. 2016;61(6):304312. https:\/\/doi.org\/10.1159\/000445044.","journal-title":"Chemotherapy"},{"key":"798_CR46","doi-asserted-by":"publisher","first-page":"115538","DOI":"10.1016\/j.bcp.2023.115538","volume":"211","author":"M He","year":"2023","unstructured":"He M, Liao Q, Liu D, et al. Dihydroergotamine mesylate enhances the anti-tumor effect of sorafenib in liver cancer cells[J]. Biochem Pharmacol. 2023;211:115538. https:\/\/doi.org\/10.1016\/j.bcp.2023.115538.","journal-title":"Biochem Pharmacol"},{"key":"798_CR47","doi-asserted-by":"publisher","first-page":"60016001","DOI":"10.1158\/1538-7445.AM2024-6001","volume":"84","author":"P Mittal","year":"2024","unstructured":"Mittal P, Lo JH, Soni S, et al. Abstract 6001: Repurposing dihydroergotamine mesylate as a potential MCL-1 inhibitor and its antitumor effect in pancreatic cancer cells[J]. Cancer Res. 2024;84:60016001. https:\/\/doi.org\/10.1158\/1538-7445.AM2024-6001.","journal-title":"Cancer Res"},{"key":"798_CR48","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12672-024-01050-9","volume":"15","author":"B Chandrasekhar","year":"2024","unstructured":"Chandrasekhar B, Gor R, Ramalingam S, et al. Repurposing FDA-approved compounds to target JAK2 for colon cancer treatment[J]. Discov Oncol. 2024;15:226. https:\/\/doi.org\/10.1007\/s12672-024-01050-9.","journal-title":"Discov Oncol"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00798-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00798-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00798-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:04:21Z","timestamp":1780322661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00798-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["798"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00798-0","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for this study was obtained from The Medical Ethics Committee of Guangxi Zhuang Autonomous Region People\u2019s Hospital (Nanning, China). All experiments involved in research projects conducted by Guangxi Zhuang Autonomous Region People\u2019s Hospital strictly adhere to the principles outlined in the\n                      Declaration of Helsinki\n                      , the internationally recognized\n                      Guidelines for the Welfare and Use of Animals in Cancer Research\n                      (doi:\n                      \n                      ), and the article\n                      American Society of Laboratory Animal Practitioners Position Statement: Humane Endpoints\n                      (doi:\n                      \n                      ).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"85"}}